AGM Statement

Genus PLC 15 November 2007 For Immediate Release 15 November 2007 Genus plc Annual General Meeting At the Annual General Meeting of Genus plc ('Genus') to be held today at 2.30pm, the Chairman, John Hawkins, will make the following statement: 'During the financial year to 30 June 2007, the first full year since we completed the Sygen acquisition that so dramatically changed the potential of the Company, we have achieved strong business growth and increased cost productivity by successfully integrating the acquired business. In the years to come, Genus' progress will continue to benefit from the increased opportunities arising from that acquisition. In the Annual Report and Financial Statements for last year's trading, we confirmed the Board's intention to divest the remaining non-core businesses to drive down debt, while ensuring that such divestments would realise good shareholder value. We also stated that we would continue to seek to increase liquidity in Genus shares. In these pursuits, in October, we completed the sale of the only remaining shrimp business, SyAqua Mexico and last week, we announced the disposal of HTSPE, the Development Consulting business. To increase liquidity in Genus shares and to reduce debt, on 6 November, we announced that we had raised £19.4m from placing 2.7 million shares with institutions at £7.20 per share. This placing is expected to be earnings enhancing as it reduces group debt to below £100m, thereby reducing the Group's average interest costs by 25 basis points. Also to improve liquidity, in parallel, we concluded a small shareholder buy- back and placing with institutional shareholders, for a total of 1.15 million shares at a price of up to £7.30 per share. 1,692 small shareholders in Genus took advantage of this low cost dealing mechanism. Trading for the new financial year has started well in the anticipated improving agricultural climate. For the first quarter, trading has been on plan, despite the weakening dollar. While we expect some uncertainty to continue in Europe, as the industry adjusts to the challenges of a changing environment, buoyancy in other markets should more than compensate for this. The Board was delighted to announce, on 12 November, the admission of trading in Genus' shares to the Official List of the London Stock Exchange. Genus was originally formed when the Milk Marketing Board was privatised in 1994 and first traded as a Public Company on OFEX in 1997, progressing to AIM in 2000. Now with a Market Capitalisation of around £420m, Genus is ranked at about 350 of the leading FTSE companies. In closing my review, I would like to offer my thanks to my colleagues on the Board for their support in our achievements, over the last 10 years, but particularly for this year. With the Company's move to the Official List, Edwin White, the Company's senior non-executive director, has indicated his intention to leave the Board during the current financial year and the Company is in the process of recruiting Mr White's successor. I would also like to compliment the management team and the staff at Genus for their achievements over this ten year period of considerable change and development of the company. The Board believes we have created a company with considerable market strength, good R&D, proven skills in managing both organic and acquisition growth and operating cost advantages from integrating the recent acquisition. This bodes well for the future of Genus in improving market conditions. To conclude, I would like to offer the Board's commitment to Genus' shareholders that, as we begin a new chapter in the development of Genus as a Listed Company, we will continue to build on the success that we have so far achieved.' For further information please contact: Genus plc Tel: 01256 347 100 Richard Wood, Chief Executive Martin Boden, Finance Director Landsbanki Securities (UK) Limited Tel: 020 7426 9000 Financial Advisor & Joint Broker Shaun Dobson Panmure Gordon (UK) Limited Tel: 020 7459 3600 Joint Broker Mark Lander Buchanan Communications Tel: 020 7466 5000 Charles Ryland Suzanne Brocks Christian Goodbody This information is provided by RNS The company news service from the London Stock Exchange

Companies

Genus (GNS)
UK 100

Latest directors dealings